Thank you for visiting our website. Our office is beginning to reopen, although our home office in San Bernardino is not fully staffed. The home office is open Monday – Thursday each week, and some Fridays We have employees working from home to answer your questions and our Consultants are available, as always. We are still conducting live webinars; please check the listings for dates and times. Please contact us at help@corcoranccg.com or leave a voicemail at (800) 399-6565. We will respond to your inquiries as soon as possible.

Medicare Reimbursement for Endoscopic Cyclophotocoagulation (ECP) (Beaver-Visitec International)

FREQUENTLY ASKED QUESTIONS: 

MEDICARE REIMBURSEMENT FOR ENDOSCOPIC CYCLOPHOTOCOAGULATION (ECP)

© Corcoran Consulting Group

Download as PDF

 For best results, please view in Mozilla Firefox.

 

Q  What is endoscopic cyclophotocoagulation?

A  Endoscopic cyclophotocoagulation (ECP) is a cyclodestructive procedure which minimizes the disadvantages of transscleral cyclodestructive procedures while maximizing the advantage of ablating the ciliary body epithelium to decrease intraocular pressure (IOP).  It uses a laser endoscope to precisely deliver laser energy to the ciliary processes which limits damage to the underlying ciliary body and surrounding tissue.1.

 

Q  What is the goal of ECP?

A  The goal of endoscopic cyclophoto-coagulation is to reduce IOP and diminish or eliminate nontolerated glaucoma medications.

 

Q  What are the indications for ECP?

A  According to the guidelines from the American Academy of Ophthalmology2. and others,3. patients with following indications may undergo ECP:

  1. Refractory glaucoma who have failed trabeculectomy or tube shunt procedures; or
  2. Minimal useful vision and elevated, poorly controlled, IOP (even with multiple medications) with or without cataracts; or
  3. Complicated, advanced glaucoma and conjunctival scarring from previous surgery; or
  4. General medical condition precludes invasive surgery or who refuse more aggressive surgery; (i.e., filter or tube shunt) or
  5. Emergency situations, such as the acute onset of neovascular glaucoma.

 

Q  Can I use ECP as a primary or initial line of treatment for glaucoma?

A  Rarely.  The medical record must explain the reason for deviating from standard of care and why medical treatment was not attempted first.  Traditionally, the medical necessity for surgery depends on the failure or contraindication of pharmaceuticals.4.

 

Q  Does Medicare cover endoscopic cyclophotocoagulation (ECP), alone or with cataract surgery?

A  Yes.  Cyclophotocoagulation of the ciliary body performed with a diode laser is a covered procedure when it is medically necessary.  Combining treatment of cataract and glaucoma in the same operation, when medically appropriate, is likewise covered.5.

 

Q  What CPT code describes ECP?

A  Use CPT code 66711 (Ciliary body destruction; cyclophotocoagulation, endoscopic).  Additionally, CPT instructs: “Do not report 66711 in conjunction with 66990.”6.

 

Q  What is the global surgery period for 66711?

A  ECP is considered a major surgical procedure with a 90-day postoperative period.

 

Q  What is the Medicare physician reimbursement for ECP?

A  The national Medicare Physician Fee Schedule for the second half of 2015 allows $652 for ECP.  This amount is adjusted by local indices.

When ECP is combined with routine cataract surgery in the same operative session, the Medicare reimbursement for the 66984, normally $650, is reduced by 50% due to the impact of the multiple surgery rule.7.

 

Q  Does Medicare allow a facility fee to an ASC or HOPD for ECP?

A  Yes.  Under current Medicare regulations, 66711 is eligible for a facility fee.  It is paid under APC 233.  The 2015 national ambulatory surgery center (ASC) allowed amount is $960.64; in the hospital outpatient department (HOPD), the allowable is $1,752.62.  Allowed amounts are adjusted by local indices.

APC 233 also contains cataract surgery; the Medicare facility payment rate is the same for ECP and cataract surgery.8.

 

Q  Can 65875 (severing posterior synechiae) be billed with 66711, since the iris is lifted with viscoelastic?

A  No.  ECP requires the use of viscoelastic to elevate the iris and provide access to the ciliary processes; breaking posterior synechiae (if any) is an incidental part of ECP.  Furthermore, NCCI bundles 65875 with 66711, so no separate reimbursement is available.

 

Q  How often is ECP performed on Medicare beneficiaries?

A  Of all glaucoma procedures performed on Medicare beneficiaries in CY 2013, the most recent year for which data is available, 3% were ECP.  Transscleral cyclophotocoagulation comprised just 1% of glaucoma procedures in the same time interval.

 

1.  Seigel, M.J.  Endoscopic Cylcophotocoagulation (ECP).  EyeWiki.  Last modified December 12, 2014.

2.  Cyclodestructive Procedures in Treatment of Glaucoma, EyeWiki, American Academy of Ophthalmology

3.  Health Net National Medical Policy.  Policy Number NMP540.  Glaucoma Surgery.  Updated July 2015.

4.  Clement, C.I., and Goldberg, I..  The management of complicated glaucoma.  Indian J Ophthalmol.  Jan 2011.

5.  Linfield, D, Ritchie, W, Griffiths, M.  ‘Phaco–ECP’: combined endoscopic cyclophotocoagulation and cataract surgery to augment medical control of glaucomaBMJ Open.  2012;2. 

6.  American Medical Association.  Current Procedural Terminology (CPT).  2015.

7.  CMS.  PFS Relative Value files.  2015.

8.  CMS.  Ambulatory Surgical Center Payment.  2015.

All links accessed 08/13/15.

 

Provided Courtesy of Beaver-Visitec International  (888) 296-8858

 

Last updated August 13, 2015

 

The reader is strongly encouraged to review federal and state laws, regulations, code sets (including ICD-9 and ICD-10), and official instructions promulgated by Medicare and other payers.  This document is not an official source nor is it a complete guide on reimbursement.  The reader is reminded that this information, including references and hyperlinks, changes over time, and may be incorrect at any time following publication.

 

© 2015 Corcoran Consulting Group.   All rights reserved.  No part of this publication may be reproduced or distributed in any form or by any means, or stored in a retrieval system, without the written permission of the publisher.

 

Corcoran Consulting Group    (800) 399-6565   www.corcoranccg.com

Website by MIC